Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
基本信息
- 批准号:7619271
- 负责人:
- 金额:$ 29.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-02 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAIDS neuropathyAIDS/HIV problemActinsAddressAdhesivesAffectAnimal ModelAnimalsAntibodiesAwardBiochemicalBiologyBlood - brain barrier anatomyBrainBrain InjuriesCCL2 geneCXCL10 geneCell CommunicationCell NucleusCell physiologyCellsCellular MorphologyCellular StructuresCentral Nervous System DiseasesCoculture TechniquesCognitive deficitsComplexCytokine Inducible SH2-Containing ProteinCytoskeletonDNA BindingDNA Sequence RearrangementDementiaElectrical ResistanceEncephalitisEndothelial CellsEndotheliumEventExtravasationFamily memberFigs - dietaryFocal AdhesionsFunctional disorderGenetic TranscriptionGenomicsGliosisHIVHIV Envelope Protein gp120HIV InfectionsHIV encephalitisHIV-1HumanIL8 geneImmuneImmunohistochemistryImpaired cognitionImpairmentIn VitroIndividualInfectionInfiltrationInflammationInflammatoryInflammatory ResponseInjuryInterleukin-6Janus kinaseLaboratoriesLeadLeukocytesLifeLigandsLinkMediatingMembraneMessenger RNAMicrofilamentsMicrogliaModelingMolecularMusNOD/SCID mouseNervous System TraumaNervous system structureNeurogliaNeurologicNeuronal InjuryNeuronsNeuropathogenesisNeurotoxinsPathogenesisPathway interactionsPatientsPermeabilityPlayProteinsProteomicsResearchResearch SupportRoleSTAT1 geneSerineSignal TransductionStress FibersStructureSystemTestingTherapeuticTight JunctionsTimeTyrosineViralViral ProteinsViremiaVirusWorkadherent junctionautocrinebasebiological systemschemokinecytokineexposed human populationfludarabinein vivoinhibitor/antagonistinjuredinsightmacrophagemigrationmonocytenovelparacrinepreventprotein inhibitor of activated STAT 1receptor bindingresearch studyresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Blood-brain barrier (BBB) compromise is common in HIV-1-infected individuals and is implicated in the pathogenesis of HIV-1-associated dementia. Breech of this barrier allows progeny virus and activated, HIV-1- infected macrophages to infiltrate the brain, disseminate virus to perivascular macrophages and microglia. Infected cells in the brain secrete neurotoxins that affect neuronal function and lead to cognitive impairments. Therefore, a principal means to prevent neurological injury following HIV-1 infection is to halt BBB injury. To accomplish this, the mechanisms through which HIV infection leads to BBB dysfunction need be elucidated. Using a defined platform, integrating genomics, proteomics and cell biological systems, we recently demonstrated that HIV-1-infected macrophages engage human brain microvascular endothelial cells and incite an autocrine and paracrine cascade of pro-inflammatory cytokines and chemokines that ultimately affect the structure and integrity of the BBB. Our preliminary work, in vitro and using brain microvessels from HIV- infected humans, demonstrated that HIV-1-induced inflammation and injury to human brain endothelial cells involve activation of STAT1 at serine 727. We further demonstrated that Fludarabine, a specific STAT1 inhibitor, reduced inflammation and viral infectivity, reduced viremia, gliosis and macrophage infiltration in the brain of HIV encephalitic mice. Based on these observations, it is our hypothesis that STAT1 play a critical role in HIV-1-induced BBB dysfunction and modulates macrophage-endothelial interactions. We hypothesize that by affecting STAT1 pathways, BBB dysfunction can be reversed leading to protection of the barrier's integrity. This hypothesis will be addressed in the following specific aims: in Aim 1, we will investigate the effects of HIV-1 and viral-induced cytokines on the endothelial cytoskeleton, and decipher the role of STAT-1 on these alterations. This is based on our preliminary observation that HIV-1-infected macrophage inflammatory responses alter the endothelial cytoskeleton. In Aim 2, we will investigate the role of STAT1 in endothelial cell function and endothelial-macrophage interaction in the context of HIV infection. Finally in Aim 3, we will test our hypothesis that STAT1 mediates HIV-induced BBB injury in vivo, using an animal model of HIV-1 encephalitis. These studies will provide insight into the mechanisms by which cytokines and HIV transduce signals at the BBB, dysregulations that occurs in HIV infection and lead to BBB dysfunction. Relevance: Forty-million people in the world are currently living with HIV/AIDS; and neurological complications are common among these infected individuals. HIV infiltrates the brain damaging the brain endothelium, then infects brain macrophages and injures neurons, resulting in cognitive deficits and sometimes dementia. The work in this proposal will help us understand how HIV damages the brain endothelium and enters the brain, how to prevent viral entry into the brain, and HIV-associated dementia.
描述(由申请人提供):血脑屏障 (BBB) 受损在 HIV-1 感染者中很常见,并且与 HIV-1 相关痴呆的发病机制有关。该屏障的破坏使得子代病毒和激活的、HIV-1感染的巨噬细胞能够渗入大脑,将病毒传播到血管周围的巨噬细胞和小胶质细胞。大脑中受感染的细胞会分泌神经毒素,影响神经元功能并导致认知障碍。因此,预防HIV-1感染后神经损伤的主要方法是阻止BBB损伤。为了实现这一目标,需要阐明 HIV 感染导致 BBB 功能障碍的机制。使用一个明确的平台,整合基因组学、蛋白质组学和细胞生物系统,我们最近证明,HIV-1感染的巨噬细胞参与人脑微血管内皮细胞,并激发促炎细胞因子和趋化因子的自分泌和旁分泌级联反应,最终影响结构和趋化因子。 BBB 的完整性。我们的初步工作是在体外并使用 HIV 感染者的脑微血管,证明 HIV-1 诱导的人脑内皮细胞炎症和损伤涉及丝氨酸 727 处 STAT1 的激活。我们进一步证明,氟达拉滨(一种特定的 STAT1 抑制剂)减少 HIV 脑炎小鼠大脑中的炎症和病毒感染性,减少病毒血症、神经胶质增生和巨噬细胞浸润。基于这些观察,我们假设 STAT1 在 HIV-1 诱导的 BBB 功能障碍和调节巨噬细胞-内皮相互作用中发挥关键作用。我们假设通过影响 STAT1 通路,可以逆转 BBB 功能障碍,从而保护屏障的完整性。这一假设将在以下具体目标中得到解决:在目标 1 中,我们将研究 HIV-1 和病毒诱导的细胞因子对内皮细胞骨架的影响,并破译 STAT-1 在这些改变中的作用。这是基于我们的初步观察,即 HIV-1 感染的巨噬细胞炎症反应会改变内皮细胞骨架。在目标 2 中,我们将研究 STAT1 在 HIV 感染情况下在内皮细胞功能和内皮巨噬细胞相互作用中的作用。最后,在目标 3 中,我们将使用 HIV-1 脑炎动物模型来检验我们的假设,即 STAT1 在体内介导 HIV 诱导的 BBB 损伤。这些研究将深入了解细胞因子和 HIV 在 BBB 上转导信号的机制,以及 HIV 感染中发生的失调并导致 BBB 功能障碍。相关性:目前世界上有四千万人感染艾滋病毒/艾滋病;神经系统并发症在这些感染者中很常见。 HIV 渗入大脑,损害脑内皮,然后感染脑巨噬细胞并损伤神经元,导致认知缺陷,有时甚至导致痴呆。该提案中的工作将帮助我们了解艾滋病毒如何损害脑内皮并进入大脑,如何防止病毒进入大脑,以及艾滋病毒相关的痴呆症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGETTE D. KANMOGNE其他文献
GEORGETTE D. KANMOGNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGETTE D. KANMOGNE', 18)}}的其他基金
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
通过靶向 CCR5 预防 HIV 感染中的阿尔茨海默病样脑部病变
- 批准号:
10700624 - 财政年份:2023
- 资助金额:
$ 29.4万 - 项目类别:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
通过靶向 CCR5 预防阿尔茨海默氏病,例如 HIV 感染中的脑病理学
- 批准号:
10161318 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
通过靶向 CCR5 预防阿尔茨海默病,例如 HIV 感染中的脑病理学
- 批准号:
10301369 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8599489 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8779742 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8257050 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8426089 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
8055998 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
7806523 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
8247819 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别:
相似海外基金
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8919084 - 财政年份:2014
- 资助金额:
$ 29.4万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8701265 - 财政年份:2013
- 资助金额:
$ 29.4万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8584593 - 财政年份:2013
- 资助金额:
$ 29.4万 - 项目类别:
Opioid Drug abuse in the context of opportunistic infection increases susceptibil
阿片类药物滥用会增加机会性感染的易感性
- 批准号:
8485569 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8599489 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别: